Opens in a new tab or window SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

TACE has been established as the standard treatment for intermediate HCC, but the long-term survival is limited. Although immunotherapy-based treatments have led to success in advanced HCC ...

SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular ...

TACE has been shown to improve survival compared with best supportive care in meta-analyses of randomized trials. HCC shows chemoresistance, thus the role of embolization might be more important ...

Methods: Consecutive HCC patients with BCLC stage A, treated by hepatectomy alone (HA) or hepatectomy with TACE (HT), were retrospectively enrolled. Propensity score matching (PSM) was used to balance ...

Like most of the TNF super family members, TNF-α is synthesized as a 26 kDa type II transmembrane protein (tmTNF), which is subsequently cleaved in the extracellular domain by the metalloprotease ...

Survival games can be weaponless, forcing players to rely on resourcefulness and strategy. Games like The Planet Crafter, WolfQuest & Astroneer offer unique gameplay experiences minus combat ...

Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC). Real-world survival differences in advanced biliary tract cancer patients with ctDNA detected IDH1 mutations ...